Evaluation of a multi‐agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non‐Hodgkin high‐grade lymphomas
Jean‐Benoit Tanis(University of Liverpool), Riccardo Finotello(University of Pisa), Sarah Mason(Addenbrooke's Hospital), I. Amores‐Fuster(University of Liverpool), Laura Blackwood(University of Edinburgh), Thomas W. Maddox(University of Liverpool), David Killick(University of Liverpool), Aaron Harper(University of Liverpool)
Cited by 18
Related Papers
Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
|BMJ|2021|843
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort
|Brain|2013|296
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
|Nature Communications|2021|149
Variation in faecal microbiota in a group of horses managed at pasture over a 12-month period
|Scientific Reports|2018|128